Increased glucose intolerance related to digoxin treatment in patients with type 2 diabetes mellitus.
Spigset
O
O
Mjörndal
T
T
D000368:Aged; D000369:Aged, 80 and over; D001786:Blood Glucose / Q000032:analysis*; D002316:Cardiotonic Agents / Q000097:blood / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D004077:Digoxin / Q000097:blood / Q000627:therapeutic use*; D017809:Fatal Outcome; D005260:Female; D018149:Glucose Intolerance / Q000503:physiopathology; D005905:Glyburide / Q000008:administration & dosage; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D008297:Male; D008687:Metformin / Q000008:administration & dosage
D001786:Blood Glucose; D002316:Cardiotonic Agents; D007004:Hypoglycemic Agents; D004077:Digoxin; D008687:Metformin; D005905:Glyburide